reimbursement

Market Access
Marketing science – brand innovation for pharma

A roadmap for adopting New Science 

The pandemic’s disruption galvanised the biopharma industry into unprecedented action, demonstrating what’s possible when the global scientific community collaborates in exceptional ways an

Market Access
The State of The U.S. Biosimilar Market: Predictions for 2021

The US biosimilar market: Predictions for 2021

It has been five years since the first biosimilar launched in the United States market—marking the first steps in expanding access to innovative biologic-based treatments that help patients